OmniAb, Inc. (OABIW) stock
OABIWNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as OABI
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 10/309% above fair value
$0.41−0.01 (-2.38%)
Close on Oct 30, 2026Market cap $742.95MP/E –Yield –
OmniAb free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
OmniAb's free cash flow for the twelve months ending Sep 30, 2026 was $2.38M. For fiscal 2025 it was -$37.02M. The highest annual figure on record is $703.00K in fiscal 2023.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$37.02M | – |
| FY2024 | Dec 31, 2024 | -$41.54M | -6008.8% |
| FY2023 | Dec 31, 2023 | $703.00K | – |
| FY2022 | Dec 31, 2022 | -$20.76M | – |
| FY2021 | Dec 31, 2021 | -$9.74M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $10.58M | – |
| Q2 FY2026 | Jun 30, 2026 | $2.57M | – |
| Q1 FY2026 | Mar 31, 2026 | -$5.08M | – |
| Q4 FY2025 | Dec 31, 2025 | -$5.68M | – |
| Q3 FY2025 | Sep 30, 2025 | -$9.95M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.31M | – |
| Q1 FY2025 | Mar 31, 2025 | -$16.08M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.92M | – |
| Q3 FY2024 | Sep 30, 2024 | -$6.73M | – |
| Q2 FY2024 | Jun 30, 2024 | -$12.93M | – |
| Q1 FY2024 | Mar 31, 2024 | -$17.96M | -165.4% |
| Q4 FY2023 | Dec 31, 2023 | -$9.23M | – |
| Q3 FY2023 | Sep 30, 2023 | -$6.69M | – |
| Q2 FY2023 | Jun 30, 2023 | -$10.84M | – |
| Q1 FY2023 | Mar 31, 2023 | $27.45M | +256.9% |
| Q4 FY2022 | Dec 31, 2022 | -$12.16M | – |
| Q3 FY2022 | Sep 30, 2022 | -$8.15M | – |
| Q2 FY2022 | Jun 30, 2022 | -$8.14M | – |
| Q1 FY2022 | Mar 31, 2022 | $7.69M | – |